⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5876917 | 0.93 | — | — | |
| SCHEMBL5876352 | 0.88 | — | — | |
| SCHEMBL5877129 | 0.88 | ERBB2 (0.33) | — | |
| SCHEMBL5877383 | 0.85 | — | — | |
| SCHEMBL5877237 | 0.84 | LDHA (0.31) | — | |
| SCHEMBL5878220 | 0.82 | — | — | |
| SCHEMBL5876284 | 0.82 | — | — | |
| SCHEMBL5877044 | 0.81 | ERBB2 (0.33) | — | |
| SCHEMBL6806630 | 0.81 | HTR7 (0.36) | — | |
| SCHEMBL6802134 | 0.81 | LRRK2 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7119115-B2 | Indazole or indole derivatives, and use thereof in human medicine and more particularly in oncology | AVENTIS PHARMA S.A. (FR) | 2006-10-10 | — | — | US | disclosed |
| US-20040162276-A1 | Indazole or indole derivatives, and use thereof in human medicine and more particularly in oncology | AVENTIS PHARMA S.A. (FR) | 2004-08-19 | — | — | US | disclosed |